Home
Data
Calendar
Blog
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 72.24 | NA | NA | NA | 70.11 | NA | NA | 63.53 | 65.15 | 48.56 | 44.28 | NA | 43.94 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 72.24 | NA | NA | NA | 70.11 | NA | NA | 63.53 | 62.60 | 50.15 | 45.95 | NA | 45.79 | 45.41 | 44.53 | NA | 44.45 | 44.45 | 11.60 | NA | 3.99 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | NA | 71.81 | 71.19 | NA | NA | 69.75 | 67.08 | NA | NA | 48.56 | 44.28 | 44.06 | 43.94 | 43.80 | 43.51 | 43.16 | 42.84 | 42.53 | 9.49 | 2.21 | 1.95 | |
| Earnings Per Share Basic | -0.90 | NA | NA | 4.04 | -1.11 | NA | NA | -0.87 | 0.03 | NA | NA | -0.37 | -0.51 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Diluted | -0.90 | NA | NA | 3.99 | -1.11 | NA | NA | -0.87 | 0.03 | NA | NA | -0.37 | -0.51 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Basic And Diluted | NA | -0.93 | -0.96 | NA | NA | -1.09 | -1.08 | NA | NA | -0.93 | -0.63 | -0.37 | -0.51 | -0.64 | -0.41 | -0.27 | -0.25 | -0.32 | -1.37 | -5.56 | -11.86 | |
| Income Loss From Continuing Operations Per Basic Share | -0.00 | NA | NA | 0.00 | -0.00 | NA | NA | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Income Loss From Continuing Operations Per Diluted Share | -0.00 | NA | NA | 0.00 | -0.00 | NA | NA | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | NA | NA | NA | NA | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 33.58 | 26.76 | 18.00 | 354.50 | 9.46 | 9.46 | 9.46 | 9.49 | 64.53 | 1.75 | 1.75 | 9.75 | 1.75 | 1.75 | 1.75 | 1.56 | 4.29 | 1.25 | 1.25 | 1.25 | 0.16 | |
| Revenues | 33.58 | 26.76 | 18.00 | 354.50 | 9.46 | 9.46 | 9.46 | 9.49 | 64.53 | 1.75 | 1.75 | 9.75 | 1.75 | 1.75 | 1.75 | 1.56 | 4.29 | 1.25 | 1.25 | 1.25 | 0.16 | |
| Operating Expenses | 102.98 | 95.74 | 85.19 | 73.23 | 87.60 | 85.60 | 82.21 | 61.50 | 62.98 | 47.12 | 30.15 | 27.28 | 25.00 | 30.91 | 20.52 | 15.05 | 16.44 | 17.15 | 14.58 | 14.59 | 23.30 | |
| Research And Development Expense | 76.68 | 69.91 | 61.21 | 49.94 | 71.25 | 68.77 | 66.39 | 48.71 | 51.80 | 35.69 | 23.14 | 20.69 | 17.24 | 25.00 | 15.55 | 11.44 | 12.86 | 13.70 | 11.65 | 12.15 | 21.43 | |
| General And Administrative Expense | 26.29 | 25.84 | 23.97 | 23.30 | 16.34 | 16.83 | 15.82 | 12.79 | 11.18 | 11.43 | 7.01 | 6.59 | 7.76 | 5.91 | 4.97 | 3.61 | 3.58 | 3.45 | 2.93 | 2.45 | 1.86 | |
| Operating Income Loss | -69.40 | -68.98 | -67.18 | 281.27 | -78.14 | -76.14 | -72.75 | -52.01 | 1.55 | -45.38 | -28.40 | -17.53 | -23.25 | -29.16 | -18.77 | -13.48 | -12.14 | -15.90 | -13.33 | -13.34 | -23.13 | |
| Allocated Share Based Compensation Expense | 16.26 | 15.68 | 16.54 | NA | 14.59 | 13.37 | 12.76 | NA | 6.00 | 4.47 | 3.46 | NA | 2.74 | 2.13 | 1.67 | NA | 1.05 | 1.12 | 0.66 | NA | 0.14 | |
| Income Tax Expense Benefit | 0.00 | 0.00 | 1.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Income Taxes Paid | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Profit Loss | -64.92 | -66.63 | -67.99 | 279.37 | -77.97 | -75.97 | -72.59 | -51.85 | 1.82 | -45.07 | -27.75 | -16.60 | -22.35 | -28.09 | -17.67 | -12.29 | -10.81 | -13.53 | -12.95 | -13.21 | NA | |
| Other Comprehensive Income Loss Net Of Tax | -2.56 | -2.58 | -3.40 | NA | -0.05 | -0.04 | -0.05 | NA | -0.06 | -0.14 | 0.22 | NA | -0.06 | 0.08 | 0.14 | NA | -0.03 | 0.01 | -0.06 | NA | NA | |
| Net Income Loss | -64.92 | -66.63 | -67.99 | 279.37 | -77.97 | -75.97 | -72.59 | -51.85 | 1.82 | -45.07 | -27.75 | -16.60 | -22.35 | -28.09 | -17.67 | -12.29 | -10.81 | -13.53 | -12.95 | -13.21 | -23.12 | |
| Comprehensive Income Net Of Tax | -67.48 | -69.22 | -71.39 | 278.20 | -78.02 | -76.01 | -72.64 | -51.89 | 1.76 | -45.22 | -27.53 | -16.59 | -22.41 | -28.01 | -17.53 | -12.29 | -10.84 | -13.52 | -13.01 | -13.24 | -23.11 |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 1393.82 | 1476.77 | 1543.43 | 1591.90 | 839.29 | 898.77 | 935.12 | 772.29 | 811.08 | 481.39 | 176.14 | 203.11 | 216.96 | 238.97 | 258.53 | 274.93 | 286.72 | 293.87 | 305.40 | 190.49 | NA | |
| Liabilities | 695.12 | 729.39 | 746.85 | 750.45 | 296.68 | 294.22 | 270.33 | 269.99 | 266.66 | 52.68 | 35.51 | 39.27 | 39.73 | 42.33 | 36.96 | 39.98 | 41.60 | 39.29 | 38.81 | 36.62 | NA | |
| Liabilities And Stockholders Equity | 1393.82 | 1476.77 | 1543.43 | 1591.90 | 839.29 | 898.77 | 935.12 | 772.29 | 811.08 | 481.39 | 176.14 | 203.11 | 216.96 | 238.97 | 258.53 | 274.93 | 286.72 | 293.87 | 305.40 | 190.49 | NA | |
| Stockholders Equity | 698.70 | 747.39 | 796.58 | 841.45 | 542.61 | 604.55 | 664.79 | 502.30 | 544.42 | 428.71 | 140.64 | 163.84 | 177.23 | 196.65 | 221.57 | 234.94 | 245.12 | 254.57 | 266.59 | -72.33 | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 1101.12 | 1227.47 | 1264.23 | 1261.75 | 545.29 | 745.95 | 841.87 | 735.82 | 797.20 | 471.60 | 166.22 | 192.71 | 200.49 | 227.73 | 245.01 | 258.95 | 265.28 | 267.44 | 282.07 | 176.87 | NA | |
| Cash And Cash Equivalents At Carrying Value | 217.65 | 272.63 | 548.78 | 147.91 | 179.43 | 320.48 | 390.26 | 173.41 | 221.85 | 285.19 | 67.33 | 57.94 | 78.99 | 76.07 | 68.50 | 71.06 | 74.89 | 170.00 | 198.12 | 98.43 | 18.31 | |
| Prepaid Expense And Other Assets Current | 21.62 | 15.67 | 18.53 | 15.62 | 17.57 | 21.97 | 8.68 | 5.47 | 11.82 | 8.66 | 8.01 | 4.30 | 4.22 | 3.27 | 3.08 | 2.32 | 2.33 | 1.55 | 1.83 | 1.14 | NA | |
| Available For Sale Securities Debt Securities | 1191.92 | 1271.11 | 1342.37 | 681.30 | NA | NA | NA | 735.09 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Net | 33.89 | 33.42 | 33.48 | 32.45 | 28.82 | 23.81 | 14.85 | 10.81 | 8.73 | 8.26 | 8.76 | 9.33 | 10.01 | 10.36 | 11.03 | 11.11 | 11.76 | 12.51 | 11.81 | 11.23 | NA | |
| Other Assets Noncurrent | 10.60 | 10.52 | 10.89 | 7.73 | 7.90 | 5.78 | 6.18 | 6.25 | 2.25 | 1.32 | 0.96 | 0.87 | 0.26 | 0.32 | 0.32 | 0.28 | 0.20 | 0.20 | 0.20 | 1.50 | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 177.18 | 164.02 | 161.25 | 166.08 | 142.87 | 130.37 | 132.06 | 121.67 | 162.87 | 40.02 | 21.00 | 22.71 | 21.06 | 26.51 | 19.00 | 16.93 | 16.61 | 16.38 | 14.26 | 12.73 | NA | |
| Accounts Payable Current | 10.55 | 21.98 | 18.09 | 10.26 | 13.22 | 16.96 | 24.54 | 15.68 | 8.10 | 12.05 | 2.43 | 4.70 | 2.90 | 2.45 | 2.83 | 3.10 | 2.11 | 5.39 | 3.92 | 3.82 | NA | |
| Accrued Income Taxes Current | 0.02 | 0.02 | 2.82 | 1.81 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Accrued Liabilities Current | 20.53 | 14.44 | 16.20 | 24.18 | 14.62 | 9.71 | 7.54 | 9.54 | 7.50 | 5.61 | 10.17 | 9.52 | 9.66 | 15.55 | 7.63 | 6.02 | 6.67 | 4.34 | 3.61 | 3.14 | NA | |
| Other Liabilities Current | 2.98 | 2.47 | NA | 0.05 | 0.21 | 0.38 | 2.38 | 3.57 | 3.42 | 1.46 | 1.41 | 1.48 | 1.49 | 1.51 | 1.54 | 1.56 | 1.58 | 1.65 | 1.73 | 0.77 | NA | |
| Contract With Customer Liability Current | 103.29 | 90.12 | 89.31 | 102.00 | 74.34 | 74.57 | 74.57 | 74.57 | 115.61 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | NA | NA | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Liabilities Noncurrent | 16.17 | 14.68 | 13.87 | 5.26 | 10.20 | 10.20 | 10.20 | 10.25 | 8.18 | 0.69 | 0.64 | 0.81 | 1.03 | 1.28 | 1.54 | 1.79 | 2.05 | 2.31 | 2.55 | 0.56 | NA | |
| Operating Lease Liability Noncurrent | 119.19 | 121.34 | 114.81 | 116.89 | 48.94 | 49.74 | 14.71 | 15.24 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | 698.70 | 747.39 | 796.58 | 841.45 | 542.61 | 604.55 | 664.79 | 502.30 | 544.42 | 428.71 | 140.64 | 163.84 | 177.23 | 196.65 | 221.57 | 234.94 | 245.12 | 254.57 | 266.59 | -72.33 | NA | |
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | NA | NA | NA | NA | NA | |
| Additional Paid In Capital | 1183.39 | 1164.60 | 1144.58 | 1118.06 | 1097.41 | 1081.34 | 1065.56 | 830.44 | 820.66 | 706.71 | 373.43 | 369.10 | 365.90 | 362.90 | 359.82 | 357.87 | 355.76 | 354.38 | 352.87 | 0.95 | NA | |
| Retained Earnings Accumulated Deficit | -474.90 | -409.98 | -343.35 | -275.35 | -554.72 | -476.75 | -400.78 | -328.18 | -276.33 | -278.15 | -233.08 | -205.33 | -188.73 | -166.38 | -138.29 | -122.83 | -110.53 | -99.72 | -86.19 | -73.23 | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -9.80 | -7.24 | -4.66 | -1.26 | -0.09 | -0.05 | -0.00 | 0.04 | 0.08 | 0.14 | 0.29 | 0.06 | 0.05 | 0.11 | 0.03 | -0.11 | -0.11 | -0.08 | -0.10 | -0.04 | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 16.26 | 15.68 | 16.54 | NA | 14.59 | 13.37 | 12.76 | NA | 6.00 | 4.47 | 3.46 | NA | 2.74 | 2.13 | 1.67 | NA | 1.05 | 1.12 | 0.66 | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -80.96 | -65.30 | 654.00 | -62.10 | -53.76 | -74.00 | -66.32 | -49.88 | 216.26 | -23.94 | -31.28 | -9.47 | -27.40 | -19.75 | -16.84 | -7.11 | -11.77 | -10.88 | -13.25 | 15.59 | -24.23 | |
| Net Cash Provided By Used In Investing Activities | 23.45 | -215.20 | -268.06 | 18.91 | -88.61 | 3.00 | 62.83 | -0.23 | -387.12 | -87.07 | 40.06 | -12.10 | 30.36 | 26.67 | 14.28 | 2.51 | -83.34 | -16.12 | -16.49 | -42.07 | 12.73 | |
| Net Cash Provided By Used In Financing Activities | 2.53 | 4.35 | 14.93 | 11.67 | 1.32 | 2.23 | 222.12 | 1.68 | 107.52 | 328.87 | 0.61 | 0.52 | -0.04 | 0.65 | -0.01 | 0.77 | -0.01 | -1.12 | 129.43 | 106.60 | 0.19 |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -80.96 | -65.30 | 654.00 | -62.10 | -53.76 | -74.00 | -66.32 | -49.88 | 216.26 | -23.94 | -31.28 | -9.47 | -27.40 | -19.75 | -16.84 | -7.11 | -11.77 | -10.88 | -13.25 | 15.59 | -24.23 | |
| Net Income Loss | -64.92 | -66.63 | -67.99 | 279.37 | -77.97 | -75.97 | -72.59 | -51.85 | 1.82 | -45.07 | -27.75 | -16.60 | -22.35 | -28.09 | -17.67 | -12.29 | -10.81 | -13.53 | -12.95 | -13.21 | -23.12 | |
| Profit Loss | -64.92 | -66.63 | -67.99 | 279.37 | -77.97 | -75.97 | -72.59 | -51.85 | 1.82 | -45.07 | -27.75 | -16.60 | -22.35 | -28.09 | -17.67 | -12.29 | -10.81 | -13.53 | -12.95 | -13.21 | NA | |
| Increase Decrease In Accounts Payable | -12.16 | 3.96 | 8.14 | 0.65 | -1.85 | -11.29 | 7.72 | 6.11 | -3.50 | 9.01 | -2.34 | 1.82 | 0.47 | -0.05 | -0.52 | 0.96 | -2.38 | 1.65 | -0.31 | 2.04 | -0.70 | |
| Share Based Compensation | 16.26 | 15.68 | 16.54 | 13.81 | 14.59 | 13.37 | 12.76 | 7.89 | 6.00 | 4.47 | 3.46 | 2.44 | 2.74 | 2.13 | 1.67 | 1.05 | 1.05 | 1.12 | 0.66 | 0.15 | 0.14 |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | 23.45 | -215.20 | -268.06 | 18.91 | -88.61 | 3.00 | 62.83 | -0.23 | -387.12 | -87.07 | 40.06 | -12.10 | 30.36 | 26.67 | 14.28 | 2.51 | -83.34 | -16.12 | -16.49 | -42.07 | 12.73 | |
| Payments To Acquire Property Plant And Equipment | 1.32 | 1.51 | 2.79 | 8.51 | 7.86 | 6.07 | 3.64 | 1.52 | 1.07 | 0.26 | 0.21 | 0.20 | 0.55 | 0.55 | 0.63 | 0.26 | 1.13 | 1.30 | 1.05 | 0.29 | 0.84 | |
| Payments To Acquire Investments | 322.26 | 385.56 | 377.57 | 134.01 | 214.16 | 178.29 | 192.40 | 170.75 | 429.21 | 130.80 | 8.88 | 67.51 | 56.41 | 51.43 | 72.41 | 39.48 | 131.40 | 49.59 | 41.08 | 59.11 | 6.28 |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | 2.53 | 4.35 | 14.93 | 11.67 | 1.32 | 2.23 | 222.12 | 1.68 | 107.52 | 328.87 | 0.61 | 0.52 | -0.04 | 0.65 | -0.01 | 0.77 | -0.01 | -1.12 | 129.43 | 106.60 | 0.19 |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 33.58 | 26.76 | 18.00 | 354.50 | 9.46 | 9.46 | 9.46 | 9.49 | 64.53 | 1.75 | 1.75 | 9.75 | 1.75 | 1.75 | 1.75 | 1.56 | 4.29 | 1.25 | 1.25 | 1.25 | 0.16 | |
| Gilead Sciences Inc And Taiho Pharmaceutical Co, License And Development Services Revenue | 23.74 | 16.69 | 7.94 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Gilead Sciences Inc And Taiho Pharmaceutical Co, Other Collaboration Revenue | 9.84 | 10.07 | 10.07 | 9.53 | 9.46 | 9.46 | 9.46 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Gilead Sciences Inc And Taiho Pharmaceutical Co, License And Service | 33.58 | 26.76 | 18.00 | 354.50 | 9.46 | 9.46 | 9.46 | 9.49 | 64.53 | 1.75 | 1.75 | 9.75 | 1.75 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 33.58 | 26.76 | 18.00 | 354.50 | 9.46 | 9.46 | 9.46 | 9.49 | 64.53 | 1.75 | 1.75 | 9.75 | 1.75 | 1.75 | 1.75 | 1.56 | 4.29 | 1.25 | 1.25 | 1.25 | 0.16 | |
| Gilead Sciences Inc, Option License And Collaboration Agreement | 2.30 | 13.20 | 5.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Gilead Access Rights | 8.32 | 8.32 | 8.32 | 7.78 | 7.71 | 7.71 | 7.71 | 7.74 | 7.68 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| License And Development Services For All Gilead Programs | 23.74 | 16.69 | 7.94 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| License And Development Services Revenue | 23.74 | 16.69 | 7.94 | 1.14 | 0.00 | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Collaboration Revenue | 9.84 | 10.07 | 10.07 | 9.53 | 9.46 | 9.46 | 9.46 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Taiho Access Rights | 1.52 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Access Rights Related To Research And Development Pipeline | 8.30 | 8.30 | 8.30 | 7.80 | 7.70 | 7.70 | 7.70 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Option License And Collaboration Agreement | 8.90 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Quemliclustat Options License And Research And Development Activities Agreement | 12.70 | 1.90 | 1.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Research And Development Activities For Domvanalimab | 0.20 | 1.30 | 0.90 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Research And Development And Commercialization Activities For Zimberelimab Monotherapy | 8.50 | 0.30 | 0.30 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
